Women’s Health Research Spotlight: Cheng-Han Lee
Genetic variant linked to hearing loss in children treated with common chemotherapy drug
New texting services launched to support first responders’ mental health
Exploring the connection between COVID-19 and ABO blood groups
It takes a village (Part 2): How Sather Clinic staff support Canadian athletes preparing for the Olympics
Digging into data, disrupting unhealthy patterns
Firefighters found to have persistent lung damage from Fort McMurray wildfire
Empowering women with mental health support
It takes a village: How Sather Clinic staff support Canadian athletes preparing for the Olympics
Species of gut bacteria linked to enhanced cognition and language skills in infant boys
Biosensors embedded in bandages could monitor diabetic foot wounds to prevent amputations
Hepatitis C vaccine could be available within five years, says U of A Nobel laureate Michael Houghton
Fecal transplant plus fibre supplements improve insulin sensitivity in severely obese patients, clinical trial shows

Hepatitis C vaccine could be available within five years, says U of A Nobel laureate Michael Houghton

Title: Hepatitis C vaccine could be available within five years, says U of A Nobel laureate Michael Houghton

Author: Michael Brown

Keywords: Michael Houghton, hepatitis C, vaccines, virology, COVID-19, Li Ka Shing Applied Virology Institute

Teaser: New vaccine has potential to save hundreds of thousands of lives each year and dramatically reduce cost of treating infections with antiviral drugs.

Link: site://folio/2021/07/hepatitis-c-vaccine-could-be-available-within-five-years-says-u-of-a-nobel-laureate-michael-houghton

Release: July 12, 2021

Departments

Research Institutes

Hepatitis C vaccine could be available within five years, says U of A Nobel laureate Michael Houghton